BIOTECH-IGG ApS: Financial statements 2013
CVR: 32099807
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
BIOTECH-IGG ApS (CVR 32099807) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 284,889 and a net result of DKK -472,561 compared with DKK -370,762 the year before. That is a decrease of 21.1% compared with the year before. Equity in the 2013 report amounted to DKK 220,695. The solvency ratio was 15.2%.
- Gross Profit
- DKK 284,889
- Profit/Loss
- DKK -472,561
- Equity
- DKK 220,695
- Total Assets
- DKK 1,449,348
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 285 t. | -473 t. | 221 t. | - |
| 2012 | - | 361 t. | -371 t. | 693 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
BIOTECH-IGG ApS has published its annual report for 2012. Gross profit came to DKK 360,896, and the net result was DKK -370,762.
As of January 7, 2013, inforevision statsautoriseret revisionsaktieselskab has been appointed auditor of BIOTECH-IGG ApS.
As of January 7, 2013, Forvis Mazars Statsautoriseret Revisionspartnerselskab has stepped down as auditor of BIOTECH-IGG ApS.
About BIOTECH-IGG ApS
BIOTECH-IGG ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2009. The company has been dissolved on 3 November 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 2 employees (2017). In 2017, the company reported a gross profit of DKK -102,019 and a net result of DKK -556,494 compared with DKK 12,659 the year before. Equity in the 2017 report amounted to DKK 633,705.